Extremely significant negative changes in Trxade Health Inc (NASDAQ: MEDS) investment behavior have recently occurred: negative upside/downside volume developed, its shorter term price trend turned down, and the stock fell on very heavy volume.
Trxade Health Inc (NASDAQ: MEDS) suffers from small negative changes in fundamentals: the stock’s power rating fell below 50.
In light of these highly negative signals we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
MEDS is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to be below the cost of capital.
Trxade Health has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. Trxade Health has a slightly negative Power Rating of 34 and a very low Appreciation Score of 2, triggering the Lowest Value Trend Rating.
Recent Price Action
Trxade Health Inc (NASDAQ: MEDS) stock closed at $7.35 on 10/31/24 after a large decline of -7.9%. Moreover, trading volume in this decline was exceptionally high at 390% of normal. The stock has been weak relative to the market over the last nine months but has risen 3.1% during the last week.
Be the first to comment